Martlet Review

About Martlet

Martlet Capital: Providing Patient Capital to Deep Technology and Life Science Startups

Martlet Capital is an early-stage investor based in Cambridge, UK. The company provides patient capital to deep technology and life science startups with high growth potential. Martlet seeks to support entrepreneurs with value beyond capital, leveraging its experience of helping companies scale from first-round through to exit.

Martlet's investment philosophy is centered around the belief that deep technology and life science startups require a different approach than traditional venture capital firms. These companies often require longer development timelines, higher levels of technical expertise, and more specialized knowledge in order to succeed.

As such, Martlet takes a long-term view when investing in these types of companies. Rather than seeking quick returns on investment, the firm is willing to provide patient capital that allows startups the time they need to develop their technologies and build sustainable businesses.

In addition to providing financial support, Martlet also offers strategic guidance and operational support for its portfolio companies. This includes access to a network of experienced entrepreneurs and industry experts who can help guide startups through various stages of growth.

One area where Martlet has particular expertise is in helping companies navigate regulatory hurdles associated with developing new technologies or bringing new products to market. The firm has experience working with regulatory bodies such as the FDA (Food & Drug Administration) in the US and EMA (European Medicines Agency) in Europe.

Martlet's focus on deep technology and life sciences has led it to invest in a range of innovative startups across various sectors including biotech, medtech, cleantech, AI/ML (artificial intelligence/machine learning), robotics, materials science, energy storage systems etc.

Some examples include:

- Cambridge Medical Robotics: A medical device company developing robotic systems for minimally invasive surgery.
- PBD Biotech: A biotech startup developing diagnostic tests for tuberculosis.
- Origami Energy: An energy storage company using advanced software algorithms for managing distributed energy resources.
- Fluidic Analytics: A medtech startup developing protein analysis tools for drug discovery and development.

Martlet's investment approach has been successful, with several of its portfolio companies achieving significant milestones such as successful clinical trials, regulatory approvals, and commercial partnerships. The firm has also seen several exits including the acquisition of Cambridge CMOS Sensors by ams AG in 2016.

In summary, Martlet Capital is an early-stage investor based in Cambridge that provides patient capital to deep technology and life science startups with high growth potential. The firm offers strategic guidance and operational support to its portfolio companies, leveraging its experience in helping startups scale from first-round through to exit. With a focus on innovative technologies across various sectors, Martlet is well-positioned to continue supporting the next generation of disruptive startups.